44 results
8-K/A
EX-99.2
ELTX
Elicio Therapeutics Inc.
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
Elicio has classified convertible preferred stock, par value $0.001 per share, (the “Preferred Stock”) as temporary equity in the accompanying consolidated … . Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement
8-K/A
EX-99.1
ELTX
Elicio Therapeutics Inc.
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
value reported in earnings.
F-8
Convertible Preferred Stock
Elicio has classified convertible preferred stock, par value $0.001 per share … will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement of operations
8-K
EX-99.5
3in8wi
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.4
fktq69
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
optgns0z
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
sn56pzgodavtb
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
424B5
liehts rl
24 May 22
Prospectus supplement for primary offering
4:02pm
424B3
h0sz73ungpss4rcdh65i
24 May 22
Prospectus supplement
4:01pm
S-3
wtv8e9jlehdizxxnita
16 May 22
Shelf registration
5:23pm
DEF 14A
w7bmjhd pxtn
27 Apr 22
Definitive proxy
4:04pm